Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
CVALF Stock — Covalon Technologies Ltd
Covalon Technologies Ltd (CVALF)
Updated October 16, 2026.
CVALF is a Stock. Total return is -85.5% over the past 19.5 years, 726.4 points behind SPY at 640.9%.
Covalon Technologies Ltd. develops and manufactures medical products for infection management, advanced wound care, and surgical procedures, using proprietary platform technologies including collagen matrix, antimicrobial silicone adhesive, and medical coating systems that it sells globally under brands including ColActive, CovaWound, and VALGuard. The company does not currently have an established distribution schedule. This equity security appeals to investors seeking exposure to specialized medical device development rather than current income.
CVALF dividend yield and income
Price as of 2026-10-16.
The ex-dividend date is 11/04/2025. The payment date is 11/18/2025.
CVALF performance versus SPY
Price and return data through 2026-10-16.
Total return is -85.5% over the past 19.5 years, 726.4 points behind SPY at 640.9%. Over the past year its total return — price change plus distributions reinvested — is 104.4%. Its deepest 1-year drawdown was 26.4%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | 10.5% | — |
| 3M | 93.2% | — |
| 6M | 97.2% | — |
| YTD | 129.0% | — |
| 1Y | 104.4% | — |
| 2Y CAGR | — | 11.60% |
| 3Y CAGR | — | 35.90% |
| 5Y CAGR | — | 8.30% |
| 10Y CAGR | — | 7.60% |
| Since inception (19.5 years) | -85.5% | -9.40% |
CVALF key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 04/17/2007
- Distribution frequency
- None
- Last close
- $2.84 (as of 2026-10-16)
- Market cap
- $78,435,339
- Average volume
- 14400.0
- Ex-dividend date
- 11/04/2025
- Payment date
- 11/18/2025
- Beta
- 0.165
- Payout ratio
- 66.8%
- P/E ratio
- 23.67
- Forward P/E
- 23.9234
- EPS
- $0.12
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
CVALF risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 26.4%.
Who may consider CVALF — and who may not
It is a weaker fit for investors who need monthly cash flow (CVALF does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on CVALF
Frequently asked questions
Does CVALF pay monthly?
No. CVALF does not currently distribute.
When does CVALF pay a dividend?
CVALF does not currently distribute. The ex-dividend date is 11/04/2025. The payment date is 11/18/2025.
How has CVALF performed?
Total return is -85.5% over the past 19.5 years, 726.4 points behind SPY at 640.9%. Over the past year its total return — price change plus distributions reinvested — is 104.4%. Its deepest 1-year drawdown was 26.4%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.